U.S. market Closed. Opens in 3 hours 41 minutes

ZOM | Zomedica Corp. Stock Overview

(Stock Exchange: AMEX)
Day's Range 0.1198 - 0.1207
52 Week Range 0.1190 - 0.2290
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 2,678,671
Average Volume 3,481,690
Shares Outstanding 979,950,000
Market Cap 117,594,000
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2017-11-21
Valuation
Profitability
Growth
Health
P/E Ratio -2.00
Forward P/E Ratio -13.95
EPS -0.06
1YR Price Target 6.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 144
Country USA
Website ZOM
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.
ZOM's peers: TLRY, ACB, CGC, HEXO, OGI, SHPH, MNK, AGRX, LFCR, AQST, LSDI, ALIM, ADMP, ATNX, CRON, SNDL
*Chart delayed
Analyzing fundamentals for ZOM we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see ZOM Fundamentals page.

Watching at ZOM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ZOM Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙